Literature DB >> 19875805

25-hydroxyvitamin D levels, race, and the progression of kidney disease.

Michal L Melamed1, Brad Astor, Erin D Michos, Thomas H Hostetter, Neil R Powe, Paul Muntner.   

Abstract

Black individuals have lower 25-hydroxyvitamin D [25(OH)D] levels and experience a disproportionate burden of ESRD compared with white individuals. Animal studies suggest that vitamin D has renoprotective effects. We evaluated the contribution of low 25(OH)D levels on incidence of ESRD using data from the Third National Health and Nutrition Examination Survey-linked Medicare claims files (n = 13,328). We included baseline (1988 through 1994) measurements of 25(OH)D and assessed the incidence of ESRD through July 31, 2001. Overall, 34% of non-Hispanic black individuals had 25(OH)D levels <15 ng/ml compared with 5% of non-Hispanic white individuals (P < 0.001). During a median of 9.1 yr, 65 participants developed ESRD. After adjustment for demographic, socioeconomic, and clinical and laboratory factors (including diabetes, hypertension, estimated GFR, and albuminuria), participants with 25(OH)D levels <15 ng/ml had a 2.6-fold greater incidence of ESRD than those with levels > or =15 ng/ml (incidence rate ratio 2.64; 95% confidence interval [CI] 1.00 to 7.05; P = 0.05). After adjustment for clinical covariates but not 25(OH)D levels, non-Hispanic black individuals had a 2.83-fold (95% CI 1.03 to 7.77) higher risk for developing ESRD compared with non-Hispanic white individuals. Additional adjustment for 25(OH)D levels reduced the risk by 58% (incidence rate ratio 1.77; 95% CI 0.38 to 8.21). In summary, low 25(OH)D levels associate with development of ESRD even after adjustment for multiple risk factors. Low 25(OH)D levels may account for a substantial proportion of the increased risk for ESRD experienced by black individuals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19875805      PMCID: PMC2794237          DOI: 10.1681/ASN.2009030283

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  55 in total

1.  Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease.

Authors:  Jared P Reis; Erin D Michos; Denise von Mühlen; Edgar R Miller
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

2.  Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women.

Authors:  M Pfeifer; B Begerow; H W Minne; D Nachtigall; C Hansen
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

3.  25-hydroxyvitamin D levels and the risk of mortality in the general population.

Authors:  Michal L Melamed; Erin D Michos; Wendy Post; Brad Astor
Journal:  Arch Intern Med       Date:  2008-08-11

4.  Partial prevention of active Heymann nephritis by 1 alpha, 25 dihydroxyvitamin D3.

Authors:  D D Branisteanu; P Leenaerts; B van Damme; R Bouillon
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

5.  MYH9 is associated with nondiabetic end-stage renal disease in African Americans.

Authors:  W H Linda Kao; Michael J Klag; Lucy A Meoni; David Reich; Yvette Berthier-Schaad; Man Li; Josef Coresh; Nick Patterson; Arti Tandon; Neil R Powe; Nancy E Fink; John H Sadler; Matthew R Weir; Hanna E Abboud; Sharon G Adler; Jasmin Divers; Sudha K Iyengar; Barry I Freedman; Paul L Kimmel; William C Knowler; Orly F Kohn; Kristopher Kramp; David J Leehey; Susanne B Nicholas; Madeleine V Pahl; Jeffrey R Schelling; John R Sedor; Denyse Thornley-Brown; Cheryl A Winkler; Michael W Smith; Rulan S Parekh
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

6.  Vitamin D levels and patient outcome in chronic kidney disease.

Authors:  Pietro Ravani; Fabio Malberti; Giovanni Tripepi; Paola Pecchini; Sebastiano Cutrupi; Patrizia Pizzini; Francesca Mallamaci; Carmine Zoccali
Journal:  Kidney Int       Date:  2008-10-08       Impact factor: 10.612

7.  25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study.

Authors:  Edward Giovannucci; Yan Liu; Bruce W Hollis; Eric B Rimm
Journal:  Arch Intern Med       Date:  2008-06-09

8.  Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group.

Authors:  W G Walker; J D Neaton; J A Cutler; R Neuwirth; J D Cohen
Journal:  JAMA       Date:  1992-12-02       Impact factor: 56.272

9.  Survival advantage of black patients with kidney disease after acute myocardial infarction.

Authors:  Britt B Newsome; William M McClellan; Christopher S Coffey; Jeroan J Allison; Catarina I Kiefe; David G Warnock
Journal:  Clin J Am Soc Nephrol       Date:  2006-07-12       Impact factor: 8.237

10.  Vitamin D deficiency and risk of cardiovascular disease.

Authors:  Thomas J Wang; Michael J Pencina; Sarah L Booth; Paul F Jacques; Erik Ingelsson; Katherine Lanier; Emelia J Benjamin; Ralph B D'Agostino; Myles Wolf; Ramachandran S Vasan
Journal:  Circulation       Date:  2008-01-07       Impact factor: 29.690

View more
  69 in total

Review 1.  Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease.

Authors:  Raimund H Pichler; Ian H de Boer
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

2.  Ethnic differences in 25-hydroxyvitamin D levels and response to treatment in CKD.

Authors:  Iris Sanchez; Roberto Mangoo-Karim; Jason R Stubbs; George P Yanev; James B Wetmore
Journal:  Int Urol Nephrol       Date:  2012-05-30       Impact factor: 2.370

3.  Phylloquinone and vitamin D status: associations with incident chronic kidney disease in the Framingham Offspring cohort.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Rachel Holden; Sarah L Booth; Caroline S Fox
Journal:  Am J Nephrol       Date:  2012-06-20       Impact factor: 3.754

4.  Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006.

Authors:  Amy L Skversky; Juhi Kumar; Matthew K Abramowitz; Frederick J Kaskel; Michal L Melamed
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

5.  Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate.

Authors:  Ian H de Boer; Ronit Katz; Michel Chonchol; Joachim H Ix; Mark J Sarnak; Michael G Shlipak; David S Siscovick; Bryan Kestenbaum
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-11       Impact factor: 8.237

6.  Ethnic Variations in Serum 25(OH)D Levels and Bone Ultrasound Attenuation Measurements in Blacks and Whites.

Authors:  Rosario Sakamoto; D Thorpe; R Knutsen; L Beeson; S Knutsen
Journal:  J Racial Ethn Health Disparities       Date:  2017-06-21

7.  Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure.

Authors:  Rebecca S Boxer; Anne M Kenny; Vinay K Cheruvu; Marianne Vest; Justin J Fiutem; Ileana I Piña
Journal:  Am Heart J       Date:  2010-11       Impact factor: 4.749

8.  Serum 25-hydroxyvitamin D level and diabetic nephropathy in patients with type 2 diabetes mellitus.

Authors:  Yan Peng; Liu-Juan Li
Journal:  Int Urol Nephrol       Date:  2015-04-24       Impact factor: 2.370

9.  Excess 25-hydroxyvitamin D3 exacerbates tubulointerstitial injury in mice by modulating macrophage phenotype.

Authors:  Yasuo Kusunoki; Isao Matsui; Takayuki Hamano; Akihiro Shimomura; Daisuke Mori; Sayoko Yonemoto; Yoshitsugu Takabatake; Yoshiharu Tsubakihara; René St-Arnaud; Yoshitaka Isaka; Hiromi Rakugi
Journal:  Kidney Int       Date:  2015-07-15       Impact factor: 10.612

10.  Vitamin D status and outcomes after renal transplantation.

Authors:  Frank Bienaimé; Delphine Girard; Dany Anglicheau; Guillaume Canaud; Jean Claude Souberbielle; Henri Kreis; Laure Hélène Noël; Gérard Friedlander; Caroline Elie; Christophe Legendre; Dominique Prié
Journal:  J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.